Your browser doesn't support javascript.
loading
Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer.
Park, Song Ee; Park, Kyunghee; Lee, Eunjin; Kim, Ji-Yeon; Ahn, Jin Seok; Im, Young-Hyuck; Lee, Choonghoon; Jung, Hun; Cho, Soo Youn; Park, Woong-Yang; Cristescu, Razvan; Park, Yeon Hee.
Afiliación
  • Park SE; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park K; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee E; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim JY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Im YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee C; Medical Affairs, MSD Korea Ltd., Seoul, Korea.
  • Jung H; Yonsei Song-Dang Institute for Cancer Research, Seoul, Korea.
  • Cho SY; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park WY; Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Cristescu R; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Park YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Oncoimmunology ; 7(8): e1466768, 2018.
Article en En | MEDLINE | ID: mdl-30221068
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2018 Tipo del documento: Article